XORTX Therapeutics Inc. submitted a 6-K filing on September 13, 2024, indicating voting results from a recent shareholders meeting. The filing specifies compliance with SEC rules under Form 20-F for foreign entities.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.